Your browser doesn't support javascript.
loading
MAF amplification licenses ERα through epigenetic remodelling to drive breast cancer metastasis.
Llorente, Alicia; Blasco, María Teresa; Espuny, Irene; Guiu, Marc; Ballaré, Cecilia; Blanco, Enrique; Caballé, Adrià; Bellmunt, Anna; Salvador, Fernando; Morales, Andrea; Nuñez, Marc; Loren, Guillem; Imbastari, Francesca; Fidalgo, Marta; Figueras-Puig, Cristina; Gibler, Patrizia; Graupera, Mariona; Monteiro, Freddy; Riera, Antoni; Holen, Ingunn; Avgustinova, Alexandra; Di Croce, Luciano; Gomis, Roger R.
Afiliación
  • Llorente A; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Blasco MT; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
  • Espuny I; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain. teresa.blasco@irbbarcelona.org.
  • Guiu M; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. teresa.blasco@irbbarcelona.org.
  • Ballaré C; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Blanco E; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Caballé A; Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Bellmunt A; Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Salvador F; Biostatistics and Bioinformatics Unit, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Morales A; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Nuñez M; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Loren G; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Imbastari F; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Fidalgo M; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Figueras-Puig C; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Gibler P; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Graupera M; Endothelial Pathobiology and Microenvironment Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.
  • Monteiro F; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Riera A; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Holen I; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
  • Avgustinova A; Endothelial Pathobiology and Microenvironment Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.
  • Di Croce L; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
  • Gomis RR; Functional Genomics Core Facility, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Nat Cell Biol ; 25(12): 1833-1847, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37945904

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Mama / Amplificación de Genes / Epigénesis Genética / Receptor alfa de Estrógeno / Proteínas Proto-Oncogénicas c-maf Límite: Animals / Female / Humans Idioma: En Revista: Nat Cell Biol Año: 2023 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Mama / Amplificación de Genes / Epigénesis Genética / Receptor alfa de Estrógeno / Proteínas Proto-Oncogénicas c-maf Límite: Animals / Female / Humans Idioma: En Revista: Nat Cell Biol Año: 2023 Tipo del documento: Article País de afiliación: España